Atyr Pharma Inc

Research Atyr Pharma Inc (ATYR) on Bullrun: market cap USD 55.54M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerATYR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 55.54M
• Financial periodFY2025
• RevenueUSD 190.00K
• Revenue growth-19.1%
• Net income-USD 74.12M
• Free cash flow-USD 62.06M

Valuation Snapshot

latest market cap is USD 55.54M.

About Atyr Pharma Inc

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs);

Frequently asked questions

What is Atyr Pharma Inc's market cap?

Atyr Pharma Inc's market capitalization is USD 55.54M.

What does Atyr Pharma Inc do?

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.